Moneycontrol
HomeNewsBusinessEarningsBetter R&D income led to jump in profits: Dishman Pharma
Trending Topics
TCS Q2 Results
TCS Q2 Results Live
Tata Motors Q1 results
Titan Q1 Preview
SBI Q1 Preview

Better R&D income led to jump in profits: Dishman Pharma

Managing director of Dishman Pharma tells CNBC-TV18 that higher earnings from its contract revenue business is what led to the surge in third quarter profits.

February 09, 2012 / 18:04 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

Managing director of Dishman Pharma, JR Vyas tells CNBC-TV18 that higher earnings from its contract revenue business is what led to the surge in profits.

TAGS: #contract revenue business #Dishman Pharma #EBITDA margins #q3 results #Results Boardroom
first published: Feb 9, 2012 02:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.